A bankruptcy judge on Friday said he would sign off on a deal that forces Purdue Pharma and its billionaire owners to pay out $7.4bn (£5.6bn) over their role in the US opioid crisis. Approval of the plan, which was first presented in January
Texas AG sues Tylenol makers over autism claims, says Big Pharma ‘betrayed’ USA

Texas Attorney General Ken Paxton on Tuesday, October 28, said he is suing makers of Tylenol, claiming they did not warn people about the risk of taking the drug during pregnancy. This lawsuit targets Johnson & Johnson and their spin-off company, Kenvue, USA Today reported.
Paxton claims the companies were aware of the potential risks of taking this drug during pregnancy. Consuming this can increase the risk of autism and attention deficit hyperactivity disorder (ADHD) in children, but they did not warn the consumers, which violates the Texas consumer protection laws.
The lawsuit also accuses Johnson & Johnson of trying to escape legal responsibility by transferring its Tylenol-related liabilities to Kenvue when it became a separate company in 2023. Paxton called the move fraudulent, saying it was designed to protect the company's assets from lawsuits.
“These corporations lied for decades, knowingly endangering millions to line their pockets,” Paxton said in a statement. “By holding Big Pharma accountable for poisoning our people, we will help Make America Healthy Again.”
In response, Kenvue called the claims “baseless” and said acetaminophen, Tylenol's main ingredient, “is the safest pain reliever option for pregnant women when used as directed.”
The company said it stands with the global medical community that supports the drug's safety and will defend itself through the legal process.
The lawsuit comes nearly a week after US President Donald Trump told pregnant women to stop taking Tylenol, mentioning its unproven link to autism in children. Since then, the debate on the safety of this drug has become more intense.
Over the years, more than two dozen studies have suggested a possible connection between frequent acetaminophen use in pregnancy and autism or ADHD. But several other studies, including a 2024 Swedish study of two million children, found no association between the pain reliever and these conditions.
Also Read: Sean Diddy's prison release date disclosed after bombshell trial and sentencing, Here's when the rapper will come out
Health experts noted that autism has many causes, including genetic and environmental factors, not just medication use during pregnancy.
Both the Society for Maternal-Fetal Medicine and the American College of Obstetricians and Gynecologists continue to state that acetaminophen remains safe for pregnant women when taken as directed.
The case adds to a growing national debate over Tylenol's safety and how drug companies handle public health risks.
Also Read: Barack Obama's gross reaction to Nancy Pelosi's Kamala Harris endorsement revealed
Texas Attorney General Ken Paxton is suing Johnson & Johnson and Kenvue, claiming they failed to warn consumers about possible risks of taking Tylenol during pregnancy and its alleged links to autism and ADHD.
Kenvue and Johnson & Johnson deny the claims, calling them baseless.
No. While some studies suggest a possible link, others, including large-scale research, have found no evidence that acetaminophen causes autism or ADHD.
Source: HindustanTimes
Related Posts: Texas Attorney General Targets 3 Businesses For Texas attorney general announces probe into ‘abuse’ of H-1B visa programme Musk slams Microsoft’s backing of OpenAI after Sam Altman's office suite remarks US attorney general criticised after saying all Epstein files released Jeremy Renner attorney says no deal was reached with Yi Zhou Boeing said to prepare for 737 output hike as soon as October Sanchar Saathi app downloads jump 10 times on Tuesday Vikran Engineering IPO to open on Tuesday Mamata Banerjee to protest against SIR on Tuesday Bengaluru Tuesday Traffic Has People Frustrated
A bankruptcy judge on Friday said he would sign off on a deal that forces Purdue Pharma and its billionaire owners to pay out $7.4bn (£5.6bn) over their role in the US opioid crisis. Approval of the plan, which was first presented in January
3 months ago